In The News: Department of Brain Health
Optimistic about the drug’s efficacy, the company has initiated its submission for accelerated FDA approval.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.
A team of neuroscientists at UNLV has reinforced the evidence for a link between type II diabetes and Alzheimer's disease.
A team of neuroscientists from the Ê×Ò³| Â鶹´«Ã½Ó³»-UNLV confirms the link between type II diabetes and Alzheimer's disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.
A new program at UNLV is addressing a critical healthcare shortage in the Las Vegas valley.
The occupational therapists in training at UNLV will one day work with people recovering from strokes, injury — and COVID-19.
Picture of UNLV School of Integrated Health Sciences students working on mobility training practices with infant dolls at the Occupational Therapy lab facility at the Shadow Lane campus.
It’s training that’s been in use for generations.
Resverlogix Corp., a world leader in epigenetics, or gene regulation, announces today new data that demonstrates their first-in-class oral small molecule BET inhibitor candidate Apabetalone significantly improves cognition and reduces cognitive decline among high-risk patients with cardiovascular disease and diabetes mellitus.
UNLV launched new Occupational Therapy program that trains students in a home instead of a classroom or lab.